WAVE LIFE SCIENCES
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.
WAVE LIFE SCIENCES
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.wavelifesciences.com
Total Employee:
251+
Status:
Active
Contact:
617-949-2900
Email Addresses:
[email protected]
Total Funding:
667 M USD
Technology used in webpage:
LetsEncrypt Pound Sterling Akamai Hosted Nginx 1.17
Similar Organizations
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Prilenia
Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Sironax
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.
TauRx Pharmaceuticals
TauRx Pharmaceuticals is a life sciences company developing drugs and diagnostics for neurodegenerative diseases.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Worg Pharmaceuticals
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases.
Current Employees Featured
Founder
Stock Details
Investors List
GlaxoSmithKline
GlaxoSmithKline investment in Post-IPO Equity - Wave Life Sciences
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Wave Life Sciences
Takeda Ventures
Takeda Ventures investment in Post-IPO Equity - Wave Life Sciences
Teva Pharmaceuticals
Teva Pharmaceuticals investment in Post-IPO Equity - Wave Life Sciences
Fidelity
Fidelity investment in Series B - Wave Life Sciences
Foresite Capital
Foresite Capital investment in Series B - Wave Life Sciences
Jennison Associates
Jennison Associates investment in Series B - Wave Life Sciences
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Wave Life Sciences
Redmile Group
Redmile Group investment in Series B - Wave Life Sciences
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Wave Life Sciences
Newest Events participated
Participated in TIDES: Oligonucleotide and Peptide Therapeutics 2017
on 2017-04-30 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.wavelifesciences.com Semrush global rank: 1.4 M Semrush visits lastest month: 18.16 K
- Host name: 104.26.6.192
- IP address: 104.26.6.192
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Wave Life Sciences"
Wave Life Sciences - Crunchbase Company Profile
Precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a …See details»
Corporate Responsibility - Wave Life Sciences
Dec 31, 2022 We have a supplier diversity program that allows us to effectively meet the needs of our organization while expanding our pool of suppliers to create more competitive business …See details»
Reimagining RNA Medicines - Wave Life Sciences
Our RNA medicines platform, PRISM ®, combines multiple modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders.Our toolkit of RNA …See details»
Leadership - Wave Life Sciences
Leadership. Our team includes some of the world’s most respected oligonucleotide chemists, drug development experts, and dedicated patient advocates.See details»
Company Wave Life Sciences Ltd. - MarketScreener.com
Jun 30, 2012 Wave Life Sciences Ltd.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: WVE | NasdaqSee details»
Wave Life Sciences | LinkedIn
Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines …See details»
Wave Life Sciences - Golden
Wave Life Sciences is a publicly traded biotechnology company based in Cambridge, Massachusetts. It focuses on designing, developing, and commercializing stereopure nucleic …See details»
WaVe Life Sciences - PitchBook
Nov 19, 2021 WaVe Life Sciences General Information Description. WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting …See details»
Working at Wave Life Sciences - Zippia
Mar 14, 2024 wavelifesciences.com. Organization Type. Public. Social Media. WaVe Life Sciences is leading a revolution in nucleic acid therapeutics and was founded on the core …See details»
Wave Life Sciences - Craft
Oct 29, 2024 Wave Life Sciences has 5 employees across 6 locations and $113.31 m in annual revenue in FY 2023. See insights on Wave Life Sciences including office locations, …See details»
WaVe Life Sciences - Work in biotech
Wave Life Sciences is developing novel oligonucleotide therapies for the treatment of rare genetic diseases. The company's PRISM platform enables the precise design, optimization, and …See details»
Wave Life Sciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of …See details»
Reimagining RNA medicine - Wave Life Sciences
Dec 31, 2020 The conference call may be accessed by dialing (866) 220-8068 (domestic) or (470) 495-9153 (international) and entering conference ID: 6269069. The live webcast may be …See details»
Patients & Families - Wave Life Sciences
Wave is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Driven by a resolute sense of urgency, …See details»
Wave Life Sciences to Present at Jefferies London - GlobeNewswire
CAMBRIDGE, Mass., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of …See details»
Reimagining RNA medicine - Wave Life Sciences
Mar 3, 2022 The conference call may be accessed by dialing (866) 220-8068 (domestic) or (470) 495-9153 (international) and entering conference ID: 7694386. The live webcast may be …See details»
Reimagining RNA medicine - Wave Life Sciences
Sep 28, 2023 Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To …See details»
Reimagining RNA medicine - ir.wavelifesciences.com
Oct 30, 2024 WVE-007 (INHBE GalNAc-siRNA for obesity) is on track to initiate a clinical trial in 1Q 2025; new preclinical data for WVE-007 demonstrate opportunities for monotherapy, for …See details»